PHERGAIN

OFFICIAL TITLE: CHEMOTHERAPY-FREE TRASTUZUMAB AND PERTUZUMAB IN HER2-POSITIVE (HUMAN EPIDERMAL RECEPTOR) BREAST CANCER: FDG-PET RESPONSE-ADAPTED STRATEGY. THE PHERGAIN STUDY

PROJECT DETAILS

THE STUDY ASSESS THE EARLY METABOLIC EFFECTS OF NEOADJUVANT TREATMENT WITH TRASTUZUMAB AND PERTUZUMAB (± ENDOCRINE THERAPY) ON THE PRIMARY TUMOR AND AXILLARY LYMPH NODES AND THEIR PREDICTIVE VALUE FOR PATHOLOGIC COMPLETE RESPONSE (PCR) IN THE BREAST AND AXILLA.

 

AND ALSO ASSESS 3-YEAR INVASIVE DISEASE-FREE SURVIVAL (IDFS) IN PATIENTS WITH HER2-POSITIVE (HER: HUMAN EPIDERMAL RECEPTOR) BREAST CANCER TREATED WITH NEOADJUVANT TRASTUZUMAB AND PERTUZUMAB (± ENDOCRINE THERAPY) USING A FDG-PET RESPONSE-ADAPTED STRATEGY.

PHERGAIN AT CLINICALTRIALS.GOV

TUMOR TYPE

PHASE

HER2+ EBC

II

377

56

Spain, Portugal, France, UK, Italia, Belgium, Germany

N

SITES

COUNTRY

STATUS

Recruitment
Closed

SABCS 2017 – DOWNLOAD THE POSTER

PHERGAIN SITES

Hospital Universitari Vall D'Hebron

SPAIN

Institut Català d' Oncologia L'Hospitalet (ICO)

SPAIN

Hospital Clínic i Provincial de Barcelona

SPAIN

Institut Català d' Oncologia Badalona (ICO)

SPAIN

Hospital Universitario La Paz

SPAIN

Hospital Universitario Virgen del Rocío

SPAIN

Hospital Universitario Reina Sofía

SPAIN

Hospital Universitario Virgen de la Victoria

SPAIN

Complejo Hospitalario de Jaén

SPAIN

Hospital Clínico Universitario de Valencia

SPAIN

Consorci Hospital General Universitari de València

SPAIN

Hospital Universitari i Politècnic La Fe

SPAIN

Instituto Valenciano de Oncología (IVO)

SPAIN

Hospital Provincial de Castellón

SPAIN

Complejo Hospitalario Universitario A Coruña (CHUAC)

SPAIN

Complejo Hospitalario Universitario de Santiago (CHUS)

SPAIN

Hospital Universitario de Burgos

SPAIN

Hospital Universitario Miguel Servet

SPAIN

Hospital Arnau de Vilanova de Valencia

SPAIN

Hospital Universitario Ramón y Cajal

SPAIN

Institut Català d' Oncologia Girona (ICO)

SPAIN

Hospital Universitari Sant Joan de Reus

SPAIN

Hospital Universitario Arnau de Vilanova de Lleida

SPAIN

Hospital Universitario Dr. Peset

SPAIN

Hospital Clínico Universitario Lozano Blesa

SPAIN

Hôpital Tenon AP-HP

FRANCE

Hopital Europeen Georges Pompidou

FRANCE

Institut Universitaire du Cancer Toulouse, Toulouse

FRANCE

Centre Paul Strauss

FRANCE

Groupe Hospitalier Diaconesses

FRANCE

CLCC d'Auvergne. Centre Jean Perrin. Clermont Ferrand

FRANCE

Institute de Cancerologie de Lorraine, Nancy

FRANCE

Ospedale Antonio Perrino

ITALY

Ospedale San Gerardo

ITALY

Instituto Europeo di Oncologia

ITALY

Istituti Ospitalieri Cremona

ITALY

Ospedale Guglielmo da Saliceto

ITALY

Ospedale S.Orsola Bologna

ITALY

Ospedale Mantova

ITALY

Barts Cancer Institute

UK

The Christie NHS Foundation Trust

UK

Royal Cornwall Hospital NHS Trust

UK

National Center for Tumor Disease (NCT)

GERMANY

Hämatologisch-Onkologische Schwerpunktpraxis

GERMANY

Kliniken Essen Mitte

GERMANY

Klinikum Rechts der Isar

GERMANY

Klinikum der Med. Fakultät Halle

GERMANY

Städtisches Klinikum „St. Georg“ Leipzig

GERMANY

Institut Jules Bordet

BELGIUM

Hospital Da Luz Lisboa

PORTUGAL

Breast Cancer Unit of Centro Hospitalar São João

PORTUGAL

Hospital Senhora da Oliveira Guimarães

PORTUGAL

Hospital Fernando da Fonseca

PORTUGAL

Centro Hospitalar de Trás-os-Montes e Alto Douro

PORTUGAL

Hospital Beatriz Ângelo

PORTUGAL

Hospital do Santo Antonio

PORTUGAL